Skip To Main Content
Anton Barchuk on Muck Rack

Anton Barchuk

As seen in: Nature, Wiley Online Library, The Lancet, Cancer Epidemiology, Biomarkers & Prevention
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Anton

Contact Anton, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 Delta variant infection: a population-based case-control study in St. Petersburg, Russia

|
By Anton Barchuk, Mikhail Cherkashin, Natalia Berezina, Anna Bulina
| medRxiv
Abstract Background: Studies of mRNA and vector-based vaccines used in different countries report acceptable levels of effectiveness against SARS-CoV-2 infection caused by the Delta variants of SARS-CoV-2. No studies estimated vaccine effectiveness (VE) of Gam-COVID-Vac and other vaccines used in Russia against symptomatic infection with Delta variant.
Open in Who Shared Issue with article?

COVID-19 pandemic in Saint Petersburg, Russia: combining surveillance and population-based serological study data in May, 2020-April, 2021

|
By Anton Barchuk, Dmitriy Skougarevskiy, Alexei Kouprianov, Daniil Shirokov
| medRxiv
View ORCID ProfileAnton Barchuk, View ORCID ProfileDmitriy Skougarevskiy, View ORCID ProfileAlexei Kouprianov, View ORCID ProfileDaniil Shirokov, View ORCID ProfileOlga Dudkina, View ORCID ProfileRustam Tursun-zade, View ORCID ProfileMariia Sergeeva, Varvara Tychkova, View ORCID ProfileAndrey Komissarov, Alena Zheltukhina, View ORCID ProfileDmitry Lioznov, View ORCID ProfileArtur Isaev, View ORCID ProfileEkaterina Pomerantseva, Svetlana Zhikrivetskaya, Yana Sofronova, View ORCID...
Open in Who Shared Issue with article?

Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study

|
By Anton Barchuk, Dmitriy Skougarevskiy, Kirill Titaev, Daniil Shirokov
| Nature Verified
Abstract Properly conducted serological survey can help determine infection disease true spread. This study aims to estimate the seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia accounting for non-response bias. A sample of adults was recruited with random digit dialling, interviewed and invited for anti-SARS-CoV-2 antibodies.
Open in Who Shared Issue with article?
See all 7 articles